PRE 14A

PRELIMINARY PROXY STATEMENT

Company: Actinium Pharmaceuticals, Inc.
Filed: November 15, 2019
Period of Report: November 15, 2019
Accession Number: 0001213900-19-023769

View Document ↗ View on SEC.gov ↗